Patents by Inventor Christopher Frederick Webber

Christopher Frederick Webber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE AND METHODS THEREOF
    Publication number: 20230218735
    Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.
    Type: Application
    Filed: June 17, 2021
    Publication date: July 13, 2023
    Inventors: Annaliesa Sybil Anderson, Alexey Vyacheslavovitch Gribenko, William Carl Gruber, Kathrin Ute Jansen, Lakshmi Khandke, Nicholas Randolph Everard Kitchin, Jody Lawrence, Yahong Peng, Michael William Pride, Christopher Frederick Webber, Sabine Susanne Wellnitz, Zhuobiao Yi
  • COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
    Publication number: 20220160859
    Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.
    Type: Application
    Filed: March 30, 2020
    Publication date: May 26, 2022
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Alexey Vyacheslavovitch Gribenko, Nicholas Randolph Everard Kitchin, Paul Liberator, Michael William Pride, Christopher Frederick Webber
  • COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
    Publication number: 20200254081
    Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, wherein the second administration is about 30 days after the first administration, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.
    Type: Application
    Filed: September 14, 2018
    Publication date: August 13, 2020
    Inventors: Kathrin Ute Jansen, Annaliesa Sybil Anderson, Robert G.K. Donald, Michael James Flint, Nicholas Randolph Everard Kitchin, Justin Keith Moran, Louise Pedneault, Michael W. Pride, Mark Edward Ruppen, Christopher Frederick Webber